Despite hundreds of off-the-shelf treatments, cancer remains one of the leading cause of death globally

In this webinar, Dr. Ming Ni, the CMC Project Manager for GenScript ProBio will provide a high-level overview of his experience in dealing with the challenges of plasmid production.

In this webinar, Leon Tian will detail GenScript ProBio’s experience and understanding in dealing with recombinant protein challenges.

Why do eukaryotic cells have introns? Our genes are frequently interspersed with noncoding introns that are commonly believed to be “junk” because they are highly unstable after splicing.

The COVID-19 pandemic has emerged as a catastrophic global emergency. The recent dramatic appearance of variants of concern of SARS-coronavirus-2 (SARS-CoV-2) highlights the need for innovative approaches that simultaneously suppress viral replication and

Speed Up and Simplify Your Antibody and Protein Purification with Magnetic Separation

Enhancing strategies for COVID-19 solutions in diagnosis, vaccine development and therapies

There are many bottlenecks in therapeutic discoveries and one of which is the identification of the right target that is specific to illicit a positive therapeutic outcome for the disease.

Success in gene and cell therapy has increased the demand for high-quality plasmid DNA production.

Neutralizing antibodies (NAbs) are critical human immune defense mechanisms against viral infections.